116 related articles for article (PubMed ID: 3320345)
21. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats.
Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A
Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber MA; Stokes GS; Gain JM
J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
[TBL] [Abstract][Full Text] [Related]
23. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Eison AS; Eison MS; Yocca FD; Gianutsos G
Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
[TBL] [Abstract][Full Text] [Related]
24. Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior.
Smith RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1990 Aug; 254(2):484-8. PubMed ID: 2166792
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
Savci V; Cavun S; Goktalay G; Ulus IH
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
27. [Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives].
Trubitsyna TK; Asnina VV; Mashkovskiĭ MD
Farmakol Toksikol; 1986; 49(1):44-9. PubMed ID: 3948987
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular actions of the primate-selective renin inhibitor, A-62198.
Kleinert HD; Martin D; Chekal M; Young G; Rosenberg S; Plattner JJ; Perun TJ
J Pharmacol Exp Ther; 1988 Sep; 246(3):975-9. PubMed ID: 3047366
[TBL] [Abstract][Full Text] [Related]
29. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
Hewson G; Leighton GE; Hill RG; Hughes J
Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats.
Knowles ID; Ramage AG
Br J Pharmacol; 1999 Oct; 128(3):530-42. PubMed ID: 10516629
[TBL] [Abstract][Full Text] [Related]
31. Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area.
Vayssettes-Courchay C; Bouysset F; Verbeuren TJ; Laubie M; Schmitt H
Eur J Pharmacol; 1991 Jan; 192(3):389-95. PubMed ID: 1675991
[TBL] [Abstract][Full Text] [Related]
32. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
Lansdown MR; Nash HL; Preston PR; Wallis DI
Br J Pharmacol; 1979 May; 66(1):80P-81P. PubMed ID: 454965
[No Abstract] [Full Text] [Related]
33. 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).
Cohen ML; Parli CJ; Fuller RW
J Pharmacol Exp Ther; 1989 Dec; 251(3):1006-11. PubMed ID: 2600800
[TBL] [Abstract][Full Text] [Related]
34. Serotonergic agonists and antagonists affect endurance performance in the rat.
Bailey SP; Davis JM; Ahlborn EN
Int J Sports Med; 1993 Aug; 14(6):330-3. PubMed ID: 8407063
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion.
Van de Kar LD; Carnes M; Maslowski RJ; Bonadonna AM; Rittenhouse PA; Kunimoto K; Piechowski RA; Bethea CL
J Pharmacol Exp Ther; 1989 Nov; 251(2):428-34. PubMed ID: 2553918
[TBL] [Abstract][Full Text] [Related]
36. Evidence for 5-HT2 receptor mediation in quipazine anorexia.
Shukla R; MacKenzie-Taylor D; Rech RH
Psychopharmacology (Berl); 1990; 100(1):115-8. PubMed ID: 2296618
[TBL] [Abstract][Full Text] [Related]
37. Plasma catecholamine, renin activity, and ACTH responses to the serotonin receptor agonist DOI in juvenile spontaneously hypertensive rats.
Bagdy G; Szemeredi K; Listwak SJ; Keiser HR; Goldstein DS
Life Sci; 1993; 53(21):1573-82. PubMed ID: 8231634
[TBL] [Abstract][Full Text] [Related]
38. Antagonism of 5-hydroxytryptamine receptors by quipazine.
Lansdown MJ; Nash HL; Preston PR; Wallis DI; Williams RG
Br J Pharmacol; 1980 Mar; 68(3):525-32. PubMed ID: 7052342
[TBL] [Abstract][Full Text] [Related]
39. Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin.
Pérgola PE; Sved AF; Voogt JL; Alper RH
Neuroendocrinology; 1993 Mar; 57(3):550-8. PubMed ID: 8321422
[TBL] [Abstract][Full Text] [Related]
40. Effect of morphine on the hemodynamic and neuroendocrine responses to hemorrhage in conscious rats.
Feuerstein G; Sirén AL; Goldstein DS; Johnson AK; Zerbe RL
Circ Shock; 1989 Mar; 27(3):219-35. PubMed ID: 2650916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
